Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–2
- High Risk3–33
The Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis calculator is designed for bedside predicting the need for venous thromboembolism (VTE) prophylaxis in hospitalized medical patients by assessing risk factors to identify patients who would benefit from thromboprophylaxis versus those at low risk who may.
Clinical Guidelines & Evidence
Predicts the need for venous thromboembolism (VTE) prophylaxis in hospitalized medical patients by assessing risk factors to identify patients who would benefit from thromboprophylaxis versus those at low risk who may not require anticoagulation
Clinical Indication
The Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis is indicated for bedside clinical practice to support Predicts the need for venous thromboembolism (VTE) prophylaxis in hospitalized medical patients by assessing risk factors to identify patients who would benefit from thromboprophylaxis versus those at low risk who may not require anticoagulation. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention. Clinical exclusion: Consider contraindications to anticoagulation before starting prophylaxis.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.
Score = Sum of all risk factors (2 points for major factors: cardiac failure, respiratory failure, recent stroke <3mo, recent MI <4wks, acute infectious disease, acute rheumatic disease, active malignancy, myeloproliferative syndrome, nephrotic syndrome, prior VTE, hypercoagulable state; 1 point for minor factors: immobilization ≥3d, recent travel >6h, age >60y, obesity BMI>30, chronic venous insufficiency, pregnancy, hormonal therapy, dehydration)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| cardiac_failure | string | Yes | Presence of cardiac failure |
| respiratory_failure | string | Yes | Presence of respiratory failure |
| recent_stroke | string | Yes | Recent stroke within 3 months |
| recent_myocardial_infarction | string | Yes | Recent myocardial infarction within 4 weeks |
| acute_infectious_disease | string | Yes | Acute infectious disease including sepsis |
| acute_rheumatic_disease | string | Yes | Acute rheumatic disease |
| active_malignancy | string | Yes | Active malignancy |
| myeloproliferative_syndrome | string | Yes | Myeloproliferative syndrome |
| nephrotic_syndrome | string | Yes | Nephrotic syndrome |
| prior_vte_history | string | Yes | Prior history of venous thromboembolism |
| known_hypercoagulable_state | string | Yes | Known hypercoagulable state |
| immobilization | string | Yes | Immobilization for 3 or more days with less than 30 minutes of walking per day |
| recent_travel | string | Yes | Recent travel longer than 6 hours |
| age_over_60 | string | Yes | Age greater than 60 years |
| obesity | string | Yes | Obesity with BMI greater than 30 kg/m² |
| chronic_venous_insufficiency | string | Yes | Chronic venous insufficiency |
| pregnancy | string | Yes | Pregnancy |
| hormonal_therapy | string | Yes | Hormonal therapy (estrogen-containing contraceptives or hormone replacement therapy) |
| dehydration | string | Yes | Dehydration |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2 | Low Risk | Low risk for VTE |
| 3–33 | High Risk | High risk for VTE |
Evidence-Based References (EBM)
- Chopard P, Spirk D, Bounameaux H. Identifying acutely ill medical patients requiring thromboprophylaxis. J Thromb Haemost. 2006;4(4):915-916. doi: 10.1111/j.1538-7836.2006.01818.x.DOI: 10.1111/j.1538-7836.2006.01818.x
- Nendaz M, Spirk D, Kucher N, et al. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). Thromb Haemost. 2014;111(3):531-538. doi: 10.1160/TH13-05-0427.DOI: 10.1160/TH13-05-0427
- Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest. 2011;139(1):69-79. doi: 10.1378/chest.09-3081.DOI: 10.1378/chest.09-3081